ArticleTranslational stroke research2020

A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease.

Lisa McKerracher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.